National Bank Of Canada Amyris, Inc. Transaction History

National Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$0.58 - $1.3 $186,760 - $418,600	-322,000 Reduced 31.67%	694,709 $715,000
Q1 2023 Apr 12, 2023	BUY	$1.09 - $1.82 $352,615 - $588,770	323,500 Added 46.67%	1,016,709 $1.38 Million
Q4 2022 Jan 24, 2023	BUY	$1.52 - $3.39 $1.05 Million - $2.35 Million	692,600 Added 113727.42%	693,209 $0
Q3 2022 Oct 13, 2022	BUY	$1.7 - $4.05 $340 - $810	200 Added 48.9%	609 $2,000
Q4 2021 Jan 24, 2022	BUY	$5.0 - $14.85 $2,045 - $6,073	409 New	409 $2,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.